| Judul | Challenges and Opportunities for Effective Cancer Immunotherapies / Michael Kershaw ; Clare Slaney |
| Pengarang | Kershaw, Michael Slaney, Clare |
| Penerbitan | Basel : MDPI - Multidisciplinary Digital Publishing Institute, 2023 |
| Deskripsi Fisik | 500 p. :ilus. |
| ISBN | 9783036569604 |
| Subjek | IMMUNOTHERAPY CANCER MEDICINE |
| Catatan | Anti-cancer immunotherapies have generated spectacular outcomes in the clinical environment and changed treatment schemes for cancer patients. Adoptive cell therapies (ACTs), including using autologous tumor-infiltrating lymphocytes and chimeric antigen receptor (CAR) T cells, and checkpoint blockades have emerged as the most effective treatments for certain cancers. The current challenge for cancer immunotherapies is that although some patients have benefited from the treatments, a number of cancers are resistant. The purpose of this Special Issue is to understand anti-cancer immunotherapy treatment resistance mechanisms and explore new options to provide opportunities for effective treatments. |
| Bentuk Karya | Tidak ada kode yang sesuai |
| Target Pembaca | Tidak ada kode yang sesuai |
| Lokasi Akses Online |
https://directory.doabooks.org/handle/20.500.12854/98947 |
| No Barcode | No. Panggil | Akses | Lokasi | Ketersediaan |
|---|---|---|---|---|
| 170726192 | 616.994 061 Cha | Baca Online | Perpustakaan Pusat - Online Resources Ebook |
Tersedia |
| Tag | Ind1 | Ind2 | Isi |
| 001 | INLIS000000000166411 | ||
| 005 | 20260212041009 | ||
| 007 | ta | ||
| 008 | 260212################|##########|#|## | ||
| 020 | # | # | $a 9783036569604 |
| 035 | # | # | $a 0010-0226000351 |
| 082 | # | # | $a 616.994 061 |
| 084 | # | # | $a 616.994 061 Cha |
| 100 | 1 | # | $a Kershaw, Michael |
| 245 | 1 | # | $a Challenges and Opportunities for Effective Cancer Immunotherapies /$c Michael Kershaw ; Clare Slaney |
| 260 | # | # | $a Basel :$b MDPI - Multidisciplinary Digital Publishing Institute,$c 2023 |
| 300 | # | # | $a 500 p. : $b ilus. |
| 505 | # | # | $a Anti-cancer immunotherapies have generated spectacular outcomes in the clinical environment and changed treatment schemes for cancer patients. Adoptive cell therapies (ACTs), including using autologous tumor-infiltrating lymphocytes and chimeric antigen receptor (CAR) T cells, and checkpoint blockades have emerged as the most effective treatments for certain cancers. The current challenge for cancer immunotherapies is that although some patients have benefited from the treatments, a number of cancers are resistant. The purpose of this Special Issue is to understand anti-cancer immunotherapy treatment resistance mechanisms and explore new options to provide opportunities for effective treatments. |
| 650 | # | # | $a CANCER |
| 650 | # | # | $a IMMUNOTHERAPY |
| 650 | # | # | $a MEDICINE |
| 700 | 1 | # | $a Slaney, Clare |
| 856 | # | # | $a https://directory.doabooks.org/handle/20.500.12854/98947 |
| 990 | # | # | $a 170726192 |
Content Unduh katalog
Karya Terkait :